7.10
-0.70%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Envoy Medical
From its filings with the US Securities and Exchange Commission
Envoy Medical is based in White Bear Lake, Minnesota. Its shares trade on Nasdaq under the ticker COCH. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $241,000 and a net loss of $23.8m. At that date it held total assets of $8.6m and shareholders' equity of −$12.2m.
FI-AMEI and we continue to work towards having the Esteem FI-AMEI properly classified as a Fully Implanted Active Middle Ear Implant.
Finally, mixed hearing loss has some combination of both sensorineural and conductive components.
This community is relatively small compared to other specialties, with only a few hundred active professionals in the United States.
Quoted from its 10-K, filed 23 Mar 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 2 Mar 2021
- Website
- anzuspac.com ↗
- Head office
- 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MN, 55110
- Classification
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Filer status
- <br>Emerging growth company
Leadership
Pay as last reported
- Mr. Charles BrynelsenNon-Executive Independent Chairman of the Board$100,000
- Mr. Brent LucasChief Executive Officer, Director, since 2023$400,542
- Mr. Robert PotashnickInterim Chief Financial Officer
- Mr. Michael CroweIndependent Director$60,415
- Ms. Susan KantorIndependent Director$100,000
- Ms. Mona PatelIndependent Director$40,000
- Ms. Janis Smith-GomezIndependent Director$40,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Operates in the Health Care Equipment & Supplies industry with a focus on hearing health solutions.
- Offers a diverse range of hearing devices including hearing aids, middle ear implants, and cochlear implants.
- Provides bone conduction hearing devices with unique features such as external components and surgically implanted fixtures.
Weaknesses
- No specific weaknesses mentioned in the provided information.
- The company's IPO date is 2021-03-02, which may indicate a relatively new market presence.
- The website provided (anzuspac.com) appears unrelated to the company's actual operations.
Opportunities
- Expanding the hearing health market by addressing various hearing loss spectrums.
- Potential growth in demand for medical technologies across the hearing loss spectrum.
- Opportunity to shift the paradigm within the hearing industry through innovative solutions.
Threats
- The company's website (anzuspac.com) is unverified and may not represent the actual company.
- No specific threats mentioned in the provided information.
- Reliance on a niche market (hearing health) could pose risks if market trends change.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.